SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richard houchin who wrote (943)7/7/1998 12:12:00 AM
From: Tulvio Durand  Read Replies (2) of 1055
 
Note that while NASI has received FDA clearance to market Pd 103, it is aiming at 1999 to meet its sources' demand for Pd 103. Does anyone know if NASI has had to show sample Pd 103 product in order to get FDA marketing approval? THRX is of the opinion that none, other than themselves, has successfully manufactured Pd 103 seeds to date. Thanks. Tulvio "... Our manufacturing capacity for I-125 sources has grown according to stated plans and the company expects to develop capacity to meet similar levels of demand for Pd-103 sources in 1999. Mentor and NASI believe that the demand for brachytherapy sources is growing strongly and are aggressively working to position themselves as a major provider of brachytherapy sources and supporting products."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext